To study the association between lower-body fat and estimates of whole-body insulin sensitivity in middle-aged men with and without a history of juvenile onset obesity, and to determine the possible mediating role of fasting serum adiponectin level as an insulin-sensitizing peptide. METHODS: A total of 401 men aged 39-65 y, body mass index 18-54 kg/m 2 , participated in the study. The following variables were measured on the study participants: regional body fat distribution as assessed by dual energy X-ray absorptiometry, abdominal sagittal diameter, maximal oxygen uptake (VO 2 max), physical activity, fasting and post-glucose load levels of plasma glucose, serum insulin, and blood non-esterified fatty acid plus fasting levels of serum adiponectin and HbA1c. RESULTS: Lower-body fat mass was positively associated with insulin sensitivity as estimated by Matsudas index also after adjusting for age, lean tissue mass, trunkal fat mass, weight changes since draft board examination, VO 2 max and the level of physical activity. In a subgroup of men selected for a large lower-body fat mass, fasting serum insulin concentration was 24% lower (Po0.01) and fasting serum adiponectin 33% higher (Po0.005) compared to a subgroup of men with a small lower-body fat mass but with similar trunkal fat mass. CONCLUSION: Lower-body fat mass is positively associated with an estimate of insulin sensitivity independently of trunkal fat mass in both lean and obese middle-aged men and this effect could partly be statistically explained by variations in serum adiponectin levels.
Introduction
It is well established that the amount of abdominal fat is inversely associated with insulin sensitivity independently of BMI. Moreover, intra-abdominal fat has been found to be a better determinant of insulin resistance than subcutaneous abdominal fat in most 1 but not all 2, 3 studies. Subcutaneous abdominal fat may be divided into superficial and deep compartments that have different morphologies where only the deep compartment may produce insulin resistance. This has been suggested by a study where the size of the two compartments was determined by computed tomography and the area of the deep subcutaneous abdominal fat explained more of the variation in fasting serum insulin concentration than visceral fat in a group of middle-aged men. 4 It is therefore likely that subcutaneous adipose tissue affects glucose metabolism differently depending on its location, despite the fact that all subcutaneous adipose tissues drain into the systemic circulation. Several epidemiological studies suggest that lower-body fat could exert an independent positive effect on insulin sensitivity. [5] [6] [7] In one particular study on post-menopausal women, fat distribution was directly measured by dualenergy X-ray absorptiometry (DXA) and lower-body fat mass was inversely associated with plasma glucose and serum insulin responses to an oral glucose tolerance test (OGTT), also after variations in trunkal fat mass were accounted for. 5 These observations suggest that some factors associated with gluteo-femoral fat, at least in women, may promote insulin sensitivity although it may be questioned whether the high insulin sensitivity is a consequence or cause of a lower-body fat distribution. In the search for possible enhancing factors on insulin action associated with lowerbody fat, adipokines that are produced at different rates in different adipose tissues should be addressed. Such a candidate is adiponectin, as it is selectively expressed in the adipocytes and appears to act on skeletal muscles to promote fat oxidation and on the liver to reduce glucose production. 8 The objective of the present study was to elucidate the independent role of the lower-body fat depot in glucose homeostasis, in middle-aged men with a different weight history. Maximal oxygen uptake (VO 2 max) and leisure time physical activity were also considered, because of their association with both body fat distribution 9 and insulin sensitivity. 10 In addition, the fasting serum concentration of adiponectin was assessed as a possible mediator of the relationship between body fat distribution and glucose metabolism.
Subjects
The participants in this study were originally sampled from men who shortly after the age of 18 y underwent the mandatory draft board examination between 1953 and 1977 on Zealand, Denmark. The initial population was composed of all the 1930 men who had a BMI Z31 kg/m 2 at the draft board examination (referred to as 'juvenile onset obese group (JOOG)' below) and a control group of 3601 men, who were randomly selected as 1% of all draft board participants (referred to as 'randomly selected group (RSG)' below). All men in the JOOG and a randomly selected 50% of the RSG form a cohort that has been invited to several subsequent follow-up studies. 11 The present one performed in 1998-2000 is the most recent. Due to death, major illness and failed tracing or refusal to participate, the number of participants in both groups was lower in this study than in the original groups. Furthermore, only subjects who were below 65 years of age and reported to be healthy and not to take any medicine regularly were invited to participate this study. In some subjects we failed to perform a successful body composition, OGTT or maximal oxygen uptake test. The number of participants included in the JOOG and RSG was 153 and 248, respectively. The study was approved by the Municipal Ethical Committee for Copenhagen and Frederiksberg. All participants signed a written consent before participation. Subject characteristics for the two study groups are shown in Table 1 . The men included in the JOOG and RSG differed as expected with regard to present BMI, but average BMI of the men in RSG also exceeded 25 kg/m 2 ( Plasma glucose was determined by the hexokinase/G6P-DH method (interassay CVo2.0%). Serum insulin was measured by the ELISA method with a narrow specificity excluding des-31, des-32 and intact proinsulin (interassay CVo6%). NEFA were analyzed in full blood on COBAS MIRA (Roche Diagnostic Systems GmbH, Mannheim, Germany) using an enzymatic analysis with acyl-CoA synthetase (ACS) and acylCoA (ACOD) with Wako NEFA C test kit (interassay CVo4%). As blood NEFA declined below the detection limit of 0.04 mmol/l in many subjects after 60 min post-load, we only used the results until that time for statistical analyses. Adiponectin was assessed from baseline serum in subjects selected for having a small-or large lower-body fat tissue mass (FTM; see statistics below) by a RIA kit purchased from LINCO Research Inc., St Charles, MO, USA, using rabbit antiadiponectin antibodies (interassay CVo10%). Body composition was measured by DXA using a Lunar DPX-IQ DXA scanner (LUNAR Radiation corporation, Madison, USA). Lean tissue mass (LTM, g), FTM (g) and bone mineral content (BMC, g) were obtained for the whole body, Lower-body fat and insulin sensitivity B Buemann et al head, arms, lower-body region and trunk. The lower-body and trunkal regions were separated by a diagonal line passing through the middle of the femoral neck (Figure 1 ), which meant that a part of the gluteal region was included in the lower-body region. Whole-body, trunkal and lower-body fat mass in percent of total tissue mass in the particular region were similarly calculated as 100
Sagittal diameter was measured on the recumbent subject as the maximal distance between a spirit level placed horizontally underneath the loin at the level of the iliac crest and a slide gauge resting on the abdomen at the same level. Waist circumference was measured on the standing subject by a nonextendable linen tape measure in accordance with the WHO recommendations. 14 Sagittal diameter and waist circumference were used in combination with trunkal fat percent and age to calculate an index for intra-abdominal adipose tissue (IAAT, cm   2 ). 15 Body weight was obtained by weighing the subjects in underwear on an electronic scale. Subjects' height was measured without shoes. VO 2 max was estimated by a progressive bicycling test. After a 5 min conditioning period, the load was increased by 20 W/min until voluntary exhaustion. The subject was instructed to pedal at a constant rate of 70 min
À1
. Yet, the ergometer adjusted the load to maintain external work effect irrespective of pedaling rate. Oxygen uptake was measured by a breath-by-breath system (Oxycon Champion, Jaeger, Würzburg, Germany). The subjects were instructed to complete questionnaires about their weekly leisure time and occupational physical activity, both of which were divided into four categories with a score from one to four: leisure time: (1) 'almost passive or light activity for less than 2 h'; (2) 'light activity such as strolling or gardening for 2-4 h'; (3) 'light activity for more than 4 h' or 'heavy activity such as fast walking or bicycling or heavy gardening or gymnastics with sweating and breathlessness for 2-4 h' and (4) 'heavy activity for more than 4 h or regular hard physical training several times per week'.
Statistical analysis
Relationships between lower-body FTM and indicators of glucose metabolism were tested by multiple linear regression analyses, with the additional inclusion of age, LTM, trunkal FTM, weight changes since draft board examination, leisure time and occupational physical activity, and VO 2 max as covariates. The RSG and JOOG were tested separately for fasting plasma glucose, fasting serum insulin and Matsudas index. Fasting serum insulin and Matsudas index were logarithmically transformed to achieve normality in the residuals. Fasting serum insulin and Matsudas index were also analyzed with the groups pooled. The latter analyses were repeated with total FTM substituted for trunkal FTM. To further elucidate the possibly independent statistical effect of lower-body FTM on glucose metabolism, we compared two selected subgroups with a small vs large lower-body FTM percent but with similar size of trunkal FTM percent. The subgroups were selected from both the RSG and JOOG. The selection procedure was performed by linear regression with lower-body FTM percent as dependent variable and trunkal FTM percent as independent variable. Individuals where the residual lower-body FTM percent was 42.5 were selected for the large lower-body FTM group, and those with a residual lower-body FTM percent oÀ2.5 were selected for the small lower-body FTM group. In both the RSG and JOOG, we sampled 44 individuals to each of the lower-body FTM subgroups by this procedure. Subjects' characteristics of the subgroups are shown in Table 2 . Markers of glucose metabolism, serum adiponectin and subjects' characteristics were compared between the lower-body FTM subgroups by Lower-body fat and insulin sensitivity B Buemann et al analyses of variance or Mann-Whitney U-test in case of lack of normality or equal variance between the groups. Subjects' characteristics that may associate with glucose metabolism have the potential statistically to explain the group differences. If these possibly biasing co-factors differed significantly between the groups and they altered the adjusted group mean difference in the tested variables by 415%, the analyses of variance were repeated with these factors included. However, hip circumference, lower-body FTM and FTM percent, total FTM percent and BMI were not regarded as biasing factors as they constituted, or were directly related to, the selection variable. If the biasing factors were mutually related, such as trunkal FTM and IAAT, only the biasing factor with the greatest impact on the adjusted mean difference was included.
The multiple regression analyses of Matsudas index based on the whole population of individuals were repeated with the subgroups where serum adiponectin results were available. As for the whole population, similarities between the RSG and JOOG in the regression coefficient of Matsudas index and lower-body fat could be achieved by logarithmic transformation of both variables. The two groups were therefore subsequently analyzed as a pooled group in the multiple regression analysis.
The slope in the decline of blood NEFA from 15 to 60 min during the OGTT was determined as individual linear regression coefficients of concentrations vs time. Time after glucose load was logarithmically transformed for the RSG to improve linearity. These slopes were subsequently compared for the small and large FTM subgroups by analyses of covariance with blood NEFA concentration at 15 min postload as a covariate. All tests were performed by SPSS 10.0 for Windows (SPSS, Chicago, IL, USA).
Results
Lower-body FTM was inversely associated with fasting serum insulin independent of age, trunkal FTM, total body LTM, aerobic capacity and physical activity. This was observed both in the JOOG, in both the individual groups and the pooled group (Table 3) . Lower-body FTM was also inversely related to fasting plasma glucose in the RSG but not in the JOOG. When the multiple regression analyses were performed pooled across the two groups, Matsudas insulin sensitivity index was positively and fasting serum insulin negatively associated with lower-body FTM (Table 3 ). This was also found if total FTM was substituted for trunkal FTM in the analyses (Po0.0005). Analyses of covariance showed that lower-body FTM did not interact with group membership in its relationship with Matsudas index and fasting serum insulin. The associations were essentially unaffected by the exclusion of the diabetic subjects. The regressions analysis with the pooled groups showed the expected inverse association between trunkal FTM and Matsudas insulin sensitivity index (b ¼ À0.76, Po0.0005). Hip circumference correlated positively with lower-body FTM in both groups (R 2 40.55, Po0.001). Lower-body FTM was 54 and 44% greater in the groups selected for a large compared to a small lower-body FTM percent in the RSG and JOOG, respectively. In the RSG, The lower-body fat percentage groups were established based on residuals being 42.5 and oÀ2.5 when lower-body FTM percent was regressed on trunkal FTM percent. Mean (95% confidence interval).
b Differences were tested by Student's t-test for unpaired observations except for these, where a Mann-Whitney U-test was applied due to lack of normality or equality of variance. c Estimated by an algorithm based on sagittal diameter, waist circumference, trunkal fat percent and age.
Lower-body fat and insulin sensitivity B Buemann et al fasting serum insulin was lower and fasting plasma glucose marginally lower in the large lower-body FTM group before accounting for biasing factors (Table 4, Figure 2 ). This difference lost statistical significance after IAAT, LTM and VO 2 max were accounted for as biasing factors (P ¼ 0.10 and 0.06, respectively, for glucose and insulin). The significantly higher Matsudas index found in the large lower-body FTM group among men in the RSG (Table 4 ) remained after the inclusion of the biasing factors, IAAT and LTM (P ¼ 0.02). The fasting serum adiponectin concentration was higher in the large lower-body FTM group among the men in the RSG (Table 4 ) and remained higher after LTM was accounted for as the only detected biasing factor. The fasting serum adiponectin level tended to be positively associated with Matsudas index also after lower-body FTM, trunkal FTM, LTM, weight changes since draft board, VO 2 max, age and physical activity measures were included in the model as b ¼ 0.12, P ¼ 0.10. Lower-body FTM remained significantly related to Matsudas index also after the inclusion of serum adiponectin level (b ¼ 0.47, Po0.0005) when data from the RSG and JOOG were merged. The JOOG exhibited no differences between the lower-body FTM groups in serum adiponectin or measures of glucose metabolism (Table 4) . This could be due to the poor similarity of the groups in other adiposity-related variables than the one matched on the trunkal FTM percent (Table 2) . However, the differences in fasting serum insulin concentration and Matsudas index were still lacking after biasing factors were accounted for.
No differences between the two lower-body FTM groups in fasting plasma NEFA concentrations were detected in the RSG or JOOG. However, in the RSG, the large lower-body FTM group showed a steeper slope in the decline in NEFA during the OGTT between 15 and 60 min post-load (large vs small FTM percent: À266 vs À244, Po0.05 after adjustment for differences in 15 min concentrations), whereas no difference was found in the JOOG.
Discussion
The present data confirm in men what previously has been found in women (5) that a greater amount of lower-body fat is associated with an increased insulin sensitivity index independently of trunkal or abdominal obesity and that variation in adiponectin may partly explain this association. Due to the fact that the sum of lower-body and trunkal FTM constituted 83% of the total FTM and explained 99.8% of its variation in our subjects, the outcomes of the statistical Only nondiabetic individuals were included to obtain normality in residuals. b Dependent variable was logarithmized to achieve normality of the residuals.
c Normality in residuals could not be obtained in the RSG group. d Lower-body FTM was logarithmized to achieve similarity between regression coefficients of the individual and merged groups. Table 4 Measures of glucose metabolism in the groups selected for high and low lower-body fat mass in the RSG and JOOG groups Lower-body fat and insulin sensitivity B Buemann et al analyses were similar when trunkal or total FTM was entered in the models. In the present study, a positive relationship between lower-body fatness and insulin sensitivity index was also demonstrated in the RSG by comparisons of groups that were selected for large vs small lower-body fat percent. Here the large lower-body fat group exhibited the highest estimate of insulin sensitivity despite a higher total body fat percent and a lower total LTM. The fact that hip circumference was similar between the two lower-body fat groups of our RSG subjects emphasizes lower-body fat as an important improving factor for glucose metabolism. Findings that individuals with large hip or thigh circumferences are characterized by a high glucose tolerance or low fasting levels of blood glucose and insulin independently of waist circumference or total subcutaneous fat 6,7,16 may therefore be explained by the positive relationship between hip circumference and lowerbody fat rather than a putative positive association between hip circumference and gluteal muscle mass. Intriguing results have been presented by Raynaud and co-workers, who found a higher insulin sensitivity, as assessed by the minimal model method, in moderately lower-body overweight women compared to age-and height-matched lean women. 17 It cannot be excluded that a large amount of lower-body fat reflects a high propensity to accumulate fat in all subcutaneous fat depots where it may have less detrimental effect on insulin sensitivity than visceral fat accumulation. However, the men in our study selected for high levels of lower-body FTM appeared to have a higher insulin sensitivity despite having an estimated amount of IAAT that did not differ essentially from that seen in the small lower-body FTM group. Another explanation may be that a high insulin sensitivity of the adipose tissue might lead to a lower-body fat distribution due to the fact that insulin sensitivity in lower-body fat appears to be higher than in abdominal fat. 18 However, a relationship with fat distribution as a primary factor affecting insulin sensitivity is also very plausible. It is well established that lower-body fat is less sensitive to lipolytic stimulation than subcutaneous abdominal fat, [19] [20] [21] which may result in less circulatory release of NEFA in individuals with a high level of lower-body fat. However, it may also be hypothesized that secretion of substances which may affect insulin action may vary between the different fat depots. In our study, serum adiponectin was positively associated with the amount of lower-body fat independently of differences in trunkal fat. A positive association between serum adiponectin concentration and insulin sensitivity has been found in a study on a mixed group of individuals, where it persisted after adjustment for differences in total body fat percent or waist to hip ratio. 22 However, factors other than adiponectin may contribute to explain the positive relationship between lower-body fat and insulin sensitivity as variations in the latter could not entirely be explained by differences in serum adiponectin in our study. There are indications of systemic factors that determine both regional fat distribution and metabolic properties of both the particular fat depots and skeletal muscles. In premenopausal obese women with similar BMI, whole-body NEFA release was higher in subjects with a high compared to low waist to hip circumference ratio (WHR), as could be expected. 23 Interestingly, however, this was not only due to a smaller NEFA release from the lower-body fat but also Lower-body fat and insulin sensitivity B Buemann et al attributable to the fact that the women with a low WHR released less NEFA from their upper body fat depots per kilogram fat mass. In line with these findings, both subcutaneous abdominal and gluteal adipocytes from upper body obese white women have been reported to be less sensitive to insulin, both with regard to the effect on lipolysis and on glucose uptake, compared to adipocytes achieved from the same sites in lower-body obese white women. 24, 25 Overall, adipose tissue insulin sensitivity may be an important conditioning factor for whole-body insulin sensitivity secondary to the antilipolytic role of insulin. Body fat distribution may be linked to regulation of glucocorticoids by the hypothalamo-pituitary-adrenal (HPA) axis as a high WHR has been reported to be associated with an impaired suppression of serum cortisol by dexamethasone. 26 Hyperactivity in the HPA axis may directly promote a central fat distribution and impair insulin action by high levels of cortisol. Furthermore, glucocorticoids appear to reduce plasma adiponectin concentration and inverse correlation has been found between urinary cortisol and plasma adiponectin in Cushing's patients. 27 Finally, cortisol may suppress testosterone production, 28 which, in turn, may contribute to the metabolic derangements. Testosterone selectively inhibits abdominal fat accumulation and replacement therapy of men with low blood testosterone concentration causes a reduction in visceral fat. 29, 30 Accordingly, a negative correlation has been found between total testosterone and WHR in younger men. 31 In parallel, testosterone within the normal range may enhance insulin sensitivity independently of its effect on fat distribution.
32,33
The beneficial metabolic effects of testosterone are unlikely to involve adiponectin as testosterone rather appears to exert a negative impact on blood levels of adiponectin, as indicated by experiments with castrated mice. 34 With regard to skeletal muscles, WHR was found to correlate positively with intramyocellular lipid accumulation of the soleus muscle in middle-aged men and this relationship could explain some of the association between WHR and insulin sensitivity found in that study. 35 Levels of plasma adiponectin may be a link between body fat distribution and intramuscular lipid accumulation as a strong inverse association has been reported between plasma adiponectin concentration and intramyocellular lipid content in adolescent subjects also after controlling for total body fat percent and central adiposity. 36 In addition to its apparent promoting effect on insulin action per se, a high-serum adiponectin level may be a marker of a high overall PPARg activity, as PPARg has been shown to stimulate adipocyte gene expression and secretion of adiponectin by in vitro experiments with thiazolidinediones. [37] [38] [39] Thus, it may be speculated that peripheral fat may be characterized by a high PPARg activity or that a high PPARg activity may lead to a peripheral fat distribution. The faster decline in plasma NEFA level during the OGTT in the large lower-body FTM subgroup among men in the RSG in the present study may reflect an increased adipose tissue uptake of NEFA, which also is in line with a high adipocyte PPARg activity. A negative correlation between NEFA area under curve (AUC) during an OGTT and plasma adiponectin, independent of total body fat percent and insulin AUC, has been reported previously. 22 The failure in our study to demonstrate a faster post-glucose decline in serum NEFA level and a higher serum adiponectin in the large lower-body FTM group in the JOOG may be due to the fact that the selected groups were not comparable with regard to trunkal FTM and BMI. In the RSG, the higher adiponectin level in the large compared to small lower-body fat group was present despite similar hip circumferences in the two subgroups. In another study, fasting serum adiponectin was found not to correlate with hip circumference independently of gender and body fat percent in a mixed population of men and women, although it correlated inversely with WHR. 40 Combined with the present results, this indicates that lower-body fat rather than other factors associated with hip circumference is responsible for variations in plasma adiponectin levels.
In conclusion, this study showed that for a certain amount of trunkal fat in middle-aged men, a large level of lower-body fat was positively associated with a high insulin sensitivity index, a finding which was independent of physical fitness. In addition, a high level of lower-body fat was associated with a high level of serum adiponectin, which may play a role in the higher level of insulin sensitivity. However, it remains to be elucidated whether the association between a high level of lower-body fat and a more efficient glucose metabolism is causal.
